Experimental HIV vaccine awaits approval for human testing

An Ontario professor has developed an experimental HIV vaccine that may be soon brought state-side for human testing.

Dr. Chil-Yong Kang, a University of Western Ontario professor, developed the vaccine, called SAV001-H . Sumagen Canada Inc, who supports the professor, says that the vaccine has been tested on animals without any identified adverse effects or safety risks.

The makers of the vaccine are waiting for approval from the U.S. Food and Drug Administration before they can begin testing the vaccine on humans.

Seventy countries around the world have already patented the vaccine.